Dexcom Inc
(DXCM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 569,000 | 285,200 | 105,400 | 576,200 | 424,500 |
| Depreciation Amortization | 186,600 | 123,000 | 60,000 | 217,700 | 159,900 |
| Income taxes - deferred | 103,300 | -14,700 | -5,800 | -43,800 | -68,100 |
| Accounts receivable | -95,700 | -333,500 | -148,900 | -35,000 | -27,600 |
| Other Working Capital | 254,400 | 22,800 | 400 | 108,800 | 102,400 |
| Other Operating Activity | 129,100 | 404,000 | 172,700 | 165,600 | 97,000 |
| Operating Cash Flow | $1,146,700 | $486,800 | $183,800 | $989,500 | $688,100 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -261,600 | -181,100 | -87,000 | -358,800 | -234,200 |
| Purchase Of Investment | -1,264,600 | -1,070,700 | -462,500 | -2,657,600 | -2,089,700 |
| Sale Of Investment | 1,755,100 | 1,288,900 | 650,200 | 2,824,400 | 2,419,200 |
| Other Investing Activity | 500 | -500 | -500 | -15,500 | 900 |
| Investing Cash Flow | $229,400 | $36,600 | $100,200 | $-207,500 | $96,200 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 28,100 | 14,200 | 14,200 | 28,200 | 28,200 |
| Common Stock Repurchased | -187,200 | N/A | N/A | -750,000 | -750,000 |
| Other Financing Activity | -5,100 | -3,400 | -1,700 | -13,000 | -11,400 |
| Financing Cash Flow | $-164,200 | $10,800 | $12,500 | $-734,800 | $-733,200 |
| Exchange Rate Effect | 17,700 | 18,800 | 2,300 | -7,400 | 3,800 |
| Beginning Cash Position | 607,300 | 607,300 | 607,300 | 567,500 | 567,500 |
| End Cash Position | 1,836,900 | 1,160,300 | 906,100 | 607,300 | 622,400 |
| Net Cash Flow | $1,229,600 | $553,000 | $298,800 | $39,800 | $54,900 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,146,700 | 486,800 | 183,800 | 989,500 | 688,100 |
| Capital Expenditure | -261,600 | -181,100 | -87,000 | -358,800 | -234,200 |
| Free Cash Flow | 885,100 | 305,700 | 96,800 | 630,700 | 453,900 |